Literature DB >> 25297445

A new pN staging system based on both the number and anatomic location of metastatic lymph nodes in gastric cancer.

Jianhui Chen1, Chuangqi Chen, Yulong He, KaiMing Wu, Hui Wu, Shirong Cai.   

Abstract

BACKGROUND: Our aim was to establish a new pN staging system for gastric cancer based on the number and location of metastatic lymph nodes (MLNs) and to compare it with other systems.
METHODS: We retrospectively analyzed the prognostic data of 521 gastric cancer patients who underwent curative resection. Survival analyses were used to establish a pN staging system that considers both the number and location of MLNs and to compare discriminatory ability and monotonicity of gradients (linear trend χ (2) score), homogeneity ability (likelihood ratio test), and prognostic stratification ability (Akaike information criterion) between Japanese Gastric Cancer Association (JGCA) and Union for International Cancer Control (UICC) systems.
RESULTS: Cut-point survival analysis divided pN(+) patients into two groups: Nxn1~6 and Nxn≥7. N0, N1, N2, and N3 (the previous classifications) were replaced by N0, N1n1~6, N2n1~6, and N1n≥7 + N2n≥7 + N3n1~6 + N3n≥7, respectively. Compared with two widely used staging systems, the new system had the highest likelihood ratio test [106.06 (new) vs 95.09 (JGCA) vs 94.33 (UICC)] and linear trend χ (2) scores [102.30 (new) vs 89.12 (JGCA) vs 86.97(UICC)] and the lowest Akaike information criterion (AIC) score [2,283.88 (new) vs 2,285.31 (JGCA) vs 2,299.88 (UICC)].
CONCLUSION: A new pN staging system based on the number and location of MLNs is an efficient prognostic indicator of the survival of patients with gastric cancer following radical surgery.

Entities:  

Mesh:

Year:  2014        PMID: 25297445     DOI: 10.1007/s11605-014-2663-5

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  25 in total

Review 1.  Surgery for gastric cancer: 10-year experience worldwide.

Authors:  Y Adachi; S Kitano; K Sugimachi
Journal:  Gastric Cancer       Date:  2001       Impact factor: 7.370

2.  Japanese gastric cancer treatment guidelines 2010 (ver. 3).

Authors: 
Journal:  Gastric Cancer       Date:  2011-06       Impact factor: 7.370

3.  Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world.

Authors:  Farin Kamangar; Graça M Dores; William F Anderson
Journal:  J Clin Oncol       Date:  2006-05-10       Impact factor: 44.544

4.  Superiority of a new UICC-TNM staging system for gastric carcinoma.

Authors:  H Hayashi; T Ochiai; T Suzuki; H Shimada; S Hori; A Takeda; Y Miyazawa
Journal:  Surgery       Date:  2000-02       Impact factor: 3.982

5.  Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. The Surgical Cooperative Group.

Authors:  A Cuschieri; P Fayers; J Fielding; J Craven; J Bancewicz; V Joypaul; P Cook
Journal:  Lancet       Date:  1996-04-13       Impact factor: 79.321

6.  The pattern of lymph node metastasis and the suitability of 7th UICC N stage in predicting prognosis of remnant gastric cancer.

Authors:  Fangxuan Li; Rupeng Zhang; Han Liang; Hui Liu; Jichuan Quan; Jingzhu Zhao
Journal:  J Cancer Res Clin Oncol       Date:  2011-11-03       Impact factor: 4.553

7.  Prediction of survival in gastric carcinoma related to lymph node grading by the new American Joint Committee on Cancer/Union International Contre le Cancer System or the Japanese system.

Authors:  Orhan Celen; Emin Yildirim; Kaptan Gülben; Uğur Berberoğlu
Journal:  Eur J Surg Suppl       Date:  2003-07

8.  The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer.

Authors:  A R Feinstein; D M Sosin; C K Wells
Journal:  N Engl J Med       Date:  1985-06-20       Impact factor: 91.245

9.  Comparative effect of lymph node metastasis classified by the anatomical site or by the number of nodes involved on prognosis of patients with gastric cancer.

Authors:  Hideki Hidaka; Tadaaki Eto; Naoki Maehara; Seiichiro Jimi; Masayuki Hotokezaka; Kazuo Chijiiwa
Journal:  Hepatogastroenterology       Date:  2008 Nov-Dec

10.  Comparison of Cancer Incidence between China and the USA.

Authors:  Yong-Chuan Wang; Li-Juan Wei; Jun-Tian Liu; Shi-Xia Li; Qing-Sheng Wang
Journal:  Cancer Biol Med       Date:  2012-06       Impact factor: 4.248

View more
  8 in total

1.  Impact of Total Number of Lymph Node Retrieval on Patients with Esophageal Carcinoma Deserves Additional Investigation.

Authors:  Hanlu Zhang; Yushang Yang; Wenping Wang; Yong Yuan; Yun Wang; Long-Qi Chen
Journal:  J Gastrointest Surg       Date:  2019-09-12       Impact factor: 3.452

2.  Surgeon Assessment of Gastric Cancer Lymph Node Specimens with a Video of Technique.

Authors:  Naruhiko Ikoma; Jeannelyn S Estrella; Wayne L Hofstetter; Jaffer A Ajani; Keith F Fournier; Paul F Mansfield; John M Skibber; Brian D Badgwell
Journal:  J Gastrointest Surg       Date:  2018-07-27       Impact factor: 3.452

3.  Central lymph node metastasis is predictive of survival in advanced gastric cancer patients treated with D2 lymphadenectomy.

Authors:  Huiwen Lu; Bochao Zhao; Rui Huang; Yimeng Sun; Zirui Zhu; Huimian Xu; Baojun Huang
Journal:  BMC Gastroenterol       Date:  2021-01-06       Impact factor: 3.067

4.  Development and validation of a novel staging system integrating the number and location of lymph nodes for gastric adenocarcinoma.

Authors:  Ziyu Li; Xiaolong Wu; Xiangyu Gao; Fei Shan; Xiangji Ying; Yan Zhang; Jiafu Ji
Journal:  Br J Cancer       Date:  2020-12-02       Impact factor: 7.640

Review 5.  Treatment Strategies and Prognostic Factors of 2018 FIGO Stage IIIC Cervical Cancer: A Review.

Authors:  Fengying Qin; Huiting Pang; Tao Yu; Yahong Luo; Yue Dong
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec

6.  The Least Nodal Disease Burden Defines the Minimum Number of Nodes Retrieved for Esophageal Squamous Cell Carcinoma.

Authors:  Hanlu Zhang; Xiuji Yan; Yu-Shang Yang; Hong Yang; Yong Yuan; Dong Tian; Yin Li; Zhi-Yong Wu; Yun Wang; Jian-Hua Fu; Long-Qi Chen
Journal:  Front Oncol       Date:  2022-03-03       Impact factor: 6.244

7.  Prognostic value of preoperative weight loss-adjusted body mass index on survival after esophagectomy for esophageal squamous cell carcinoma.

Authors:  Han-Lu Zhang; Yu-Shang Yang; Jia-Nan Duan; Qi-Xin Shang; Song-Lin He; Yi-Min Gu; Wei-Peng Hu; Wen-Ping Wang; Yang Hu; Yun Wang; Yong Yuan; Long-Qi Chen
Journal:  World J Gastroenterol       Date:  2020-02-28       Impact factor: 5.742

8.  Comparison of different lymph node staging systems in patients with node-positive cervical squamous cell carcinoma following radical surgery.

Authors:  Qinhao Guo; Jun Zhu; Yong Wu; Hao Wen; Lingfang Xia; Min Yu; Simin Wang; Xingzhu Ju; Xiaohua Wu
Journal:  J Cancer       Date:  2020-10-23       Impact factor: 4.207

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.